Contact Information
Company Information
Company
Foghorn Therapeutics, Inc
Annual Revenue
22602000.0
Technologies
Salesforce
Amazon SES
Outlook
CloudFlare Hosting
Workable
Adobe Marketing Cloud
Vimeo
Mobile Friendly
BugHerd
Google Tag Manager
reCAPTCHA
Typekit
WordPress.org
IoT
Remote
AI
Keywords
biotechnology: pharmaceutical preparations
health care
biotechnology research
chromatin regulation
precision medicine
gene expression
therapeutic candidates
epigenetic modulation
cancer treatment
oncology
abnormal gene expression
gene traffic control
chromatin remodeling
biotechnology
rna regulation
dna structure
small molecules
targeted therapies
therapeutic interventions
disease dependencies
pharmaceutical collaboration
drug discovery
clinical development
biopharmaceuticals
therapeutics
preclinical studies
cancer research
oncogenomics
target identification
molecular biology
protein degradation
baf complex
transcription factors
cell differentiation
cancer biology
medical research
drug design
genetic insights
cell therapy
biomarkers
gene therapy
small molecule inhibitors
drug candidate
biotech innovation
research partnerships
pharmaceutical development
medicinal chemistry
translational medicine
clinical trials
therapeutic platforms
biological science
anti-cancer strategies
chromatin regulatory system
gene expression modulation
oncology therapies
genetic disorders
smarca4 mutations
gene traffic control platform
proteolysis targeting chimera
ep300 degraders
arid1b degraders
clinical-stage biotechnology
innovative medicines
personalized treatments
dysregulated gene expression
patient-centric approach
collaborative innovation
biotechnology industry
pharmaceutical sector
genetic abnormalities
therapeutic innovation
patient advocacy
healthcare providers
regulatory compliance
strategic partnerships
market potential
competitive advantage
health
wellness & fitness
hospital & health care
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans